| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |